Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (21-30 of 298) with videos related to

Pageof 30
Sort By:
Proceedings (Baylor University. Medical Center)|January 26, 2012
An unusual facial ulcerAmanda Abramson, Alan Menter
Expert Opinion on Investigational Drugs|October 1, 2016
A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studiesMolly Campa, Alan Menter
JAMA Dermatology|October 15, 2015
Reporting of MABp1 for the Treatment of PsoriasisBobbak Mansouri, Alan Menter
Proceedings (Baylor University. Medical Center)|January 2, 2015
The Laugier-Hunziker syndromeTahmina Mahmood, Alan Menter
Lancet (London, England)|August 16, 2014
Ponesimod--a future oral therapy for psoriasis?Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|August 17, 2014
Complementary data for long-term infliximab use in psoriasisBobbak Mansouri, Alan Menter
Expert Review of Clinical Immunology|January 14, 2014
Ustekinumab for the treatment of psoriatic arthritisJay Wofford, Alan Menter
Expert Opinion on Biological Therapy|April 19, 2005
Efalizumab: continuous therapy for chronic psoriasisJennifer Clay Cather, Alan Menter
Dermatologic Therapy|September 24, 2004
InfliximabLaura S Winterfield, Alan Menter
Proceedings (Baylor University. Medical Center)|January 2, 2016
Recurrent lumbosacral herpes simplex virus infectionJanna M Vassantachart, Alan Menter
Pageof 30

Showing results (21-30 of 298) with videos related to

Sort By:
Pageof 30
Proceedings (Baylor University. Medical Center)|January 26, 2012
An unusual facial ulcerAmanda Abramson, Alan Menter
Expert Opinion on Investigational Drugs|October 1, 2016
A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studiesMolly Campa, Alan Menter
JAMA Dermatology|October 15, 2015
Reporting of MABp1 for the Treatment of PsoriasisBobbak Mansouri, Alan Menter
Proceedings (Baylor University. Medical Center)|January 2, 2015
The Laugier-Hunziker syndromeTahmina Mahmood, Alan Menter
Lancet (London, England)|August 16, 2014
Ponesimod--a future oral therapy for psoriasis?Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|August 17, 2014
Complementary data for long-term infliximab use in psoriasisBobbak Mansouri, Alan Menter
Expert Review of Clinical Immunology|January 14, 2014
Ustekinumab for the treatment of psoriatic arthritisJay Wofford, Alan Menter
Expert Opinion on Biological Therapy|April 19, 2005
Efalizumab: continuous therapy for chronic psoriasisJennifer Clay Cather, Alan Menter
Dermatologic Therapy|September 24, 2004
InfliximabLaura S Winterfield, Alan Menter
Proceedings (Baylor University. Medical Center)|January 2, 2016
Recurrent lumbosacral herpes simplex virus infectionJanna M Vassantachart, Alan Menter
Pageof 30